國立虎尾科技大學 |

Ethics and the pharmaceutical industry /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Ethics and the pharmaceutical industry // edited by Michael A. Santoro, Thomas M. Gorrie.
remainder title:	Ethics & the Pharmaceutical Industry
other author:	Santoro, Michael A.,
Description:	1 online resource (xxxiv, 492 pages) :digital, PDF file(s). :
Notes:	Title from publisher's bibliographic system (viewed on 05 Oct 2015).
Subject:	Pharmaceutical industry. -
Online resource:	https://doi.org/10.1017/CBO9780511610769
ISBN:	9780511610769 (ebook)

Ethics and the pharmaceutical industry /
Ethics and the pharmaceutical industry /Ethics & the Pharmaceutical Industryedited by Michael A. Santoro, Thomas M. Gorrie. - 1 online resource (xxxiv, 492 pages) :digital, PDF file(s).

Title from publisher's bibliographic system (viewed on 05 Oct 2015).

Drug research: between ethical demands and economic constraints / Jürgen Drews -- Emerging international norms for clinical testing: good clinical trial practice / Juhana E. Idänpään-Heikkilä, Sev Fluss -- The regulatory and ethical challenges of pediatric research / M. Dianne Murphy, Sara F. Goldkind -- Including children in research: participation or exploitation? / Robert M. Nelson -- Racial and ethnic inclusiveness in clinical trials / Valentine J. Burroughs -- The rights of patients to participate in clinical research / Glenna M. Crooks -- How should government regulate stem-cell research? views from a scientist-legislator / Rush Holt -- Ethics and prescribing: the clinician's perspective / Charles L. Bardes -- The regulation of prescription drug promotion / Thomas Abrams.

Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Government officials and social critics have questioned whether the multibillion-dollar industry is fulfilling its social responsibilities. This doubt has been fueled by the national debate over drug pricing and affordable healthcare, and internationally by the battles against epidemic diseases, such as AIDS, in the developing world. Debates are raging over how the industry can and should be expected to act. The contributions in this book by leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, and marketing.

ISBN: 9780511610769 (ebook)Subjects--Topical Terms:

581826
Pharmaceutical industry.

LC Class. No.: HD9665.5 / .E85 2005

Dewey Class. No.: 338.4/76151

Ethics and the pharmaceutical industry /
LDR:04382nam a2200337 i 4500 001 1122409
003 UkCbUP
005 20151005020623.0
006 m|||||o||d||||||||
007 cr||||||||||||
008 240926s2005||||enk o ||1 0|eng|d
020 $a 9780511610769 (ebook)
020 $z 9780521854962 (hardback)
020 $z 9780521708883 (paperback)
035 $a CR9780511610769
040 $a UkCbUP $b eng $e rda $c UkCbUP
050 0 0 $a HD9665.5 $b .E85 2005
082 0 0 $a 338.4/76151 $2 22
245 0 0 $a Ethics and the pharmaceutical industry / $c edited by Michael A. Santoro, Thomas M. Gorrie.
246 3 $a Ethics & the Pharmaceutical Industry
264 1 $a Cambridge : $b Cambridge University Press, $c 2005.
300 $a 1 online resource (xxxiv, 492 pages) : $b digital, PDF file(s).
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Title from publisher's bibliographic system (viewed on 05 Oct 2015).
505 0 $a Drug research: between ethical demands and economic constraints / Jürgen Drews -- Emerging international norms for clinical testing: good clinical trial practice / Juhana E. Idänpään-Heikkilä, Sev Fluss -- The regulatory and ethical challenges of pediatric research / M. Dianne Murphy, Sara F. Goldkind -- Including children in research: participation or exploitation? / Robert M. Nelson -- Racial and ethnic inclusiveness in clinical trials / Valentine J. Burroughs -- The rights of patients to participate in clinical research / Glenna M. Crooks -- How should government regulate stem-cell research? views from a scientist-legislator / Rush Holt -- Ethics and prescribing: the clinician's perspective / Charles L. Bardes -- The regulation of prescription drug promotion / Thomas Abrams.
505 0 $a A future agenda for government-industry relations / William C. Weldon -- AIDS activism and the pharmaceutical industry / Martin Delaney -- The campaign against innovation / Sidney Taurel -- Third world perspectives on global pharmaceutical access / James Thuo Gathii -- The promise of vaccines and the influenza vaccine shortage of 2004: public and private partnerships / Gary R. Noble -- Evolving approaches to healthcare challenges / Thomas M. Gorrie -- Property rights in crisis: managers and rescue / Nien-hê Hsieh -- Blurring the lines: public and private partnerships addressing global health / William H. Foege -- Renegotiating the grand bargain: balancing prices, profits, people, and principles / Edward Greg Koski.
505 0 $a Direct-to-consumer advertising of prescription drugs: a policy dilemma / Meredith B. Rosenthal, Julie M. Donohue -- Off-label communications and prescription drugs / Schott D. Danzis -- The need for better health information: advancing the informed patient in Europe / Don E. Detmer, Peter Singleton, Scott C. Ratzan -- Who should get access to which drugs? an ethical template for pharmacy benefits / Norman Daniels, James E. Sabin, J. Russell Teagarden -- The application of cost-effectiveness and cost-benefit analysis to pharmaceuticals / Joel W. Hay -- Intellectual property rights, access to life-enhancing drugs, and corporate moral responsibilities / Patricia H. Werhande, Michael E. Gorman.
520 $a Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Government officials and social critics have questioned whether the multibillion-dollar industry is fulfilling its social responsibilities. This doubt has been fueled by the national debate over drug pricing and affordable healthcare, and internationally by the battles against epidemic diseases, such as AIDS, in the developing world. Debates are raging over how the industry can and should be expected to act. The contributions in this book by leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, and marketing.
650 0 $a Pharmaceutical industry. $3 581826
650 0 $a Drugs $x Marketing $x Moral and ethical aspects. $3 1438580
650 0 $a Drugs $x Research $x Moral and ethical aspects. $3 1438581
650 0 $a Medical innovations $x Social aspects. $3 800435
650 0 $a Social responsibility of business. $3 558803
700 1 $a Santoro, Michael A., $e editor. $3 1438578
700 1 $a Gorrie, Thomas M., $e editor. $3 1438579
776 0 8 $i Print version: $z 9780521854962
856 4 0 $u https://doi.org/10.1017/CBO9780511610769